Register now for 2026-27

Registrations are now open for the 2026–27 period (1 September 2026 to 31 August 2027).

Read our article on how to register, renew, calculate your registration cost or complete a non-renewal form.

Completed - 11 evaluations (published 26 June 2026)

These evaluation statements cover the human health and environmental risks of certain chemicals on the Inventory and one chemical not on the Inventory (retinal).

We consulted on the draft evaluations between 1 April 2026 and 28 May 2026.

Updates to our evaluations workplan and request for chemical information

We've initiated 9 new evaluations, bringing the total number in our Rolling Action Plan to 14. The RAP outlines why each chemical is being evaluated, the evaluation focus and expected timeframes. It includes both Inventory chemicals and 1 chemical not on the Inventory.

We're also seeking specific information on 4 evaluations covering 9 chemicals. 

Retinal introductions for consumer use now need AICIS assessment 

From 27 June 2026, businesses can no longer introduce retinal (retinaldehyde; CAS 116-31-4) under the AICIS exempted or reported categories where it has a consumer end use, including in cosmetics and skincare products.

This change follows our recent targeted human health hazard assessment of retinal.

An AICIS assessment certificate is now required, with a reduced-fee comparable hazard assessment option available.

Variations to chemicals on the Inventory after evaluation

CAS number
616-45-5
CAS name
2-pyrrolidinone
Read the 7 July 2026 notice

CAS number
2128-93-0
CAS name
methanone,[1,1'-biphenyl]-4-ylphenyl-
Read the 7 July 2026 notice